Evidence of involvement of the human Par-4 (PAWR) gene in major depressive disorder

World Journal of Biological Psychiatry

Volumn 12, Issue 4, 2011, Pages 288-295

  Liou, Ying Jay ^a,b   Chen, Tai Jui ^c   Tsai, Shih Jen ^a,b   Yu, Younger W Y ^d   Chen, Shiow Yi ^e   Cheng, Chih Ya ^a   Hong, Chen Jee ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

^d Yu's Psychiatric Clinic   (Taiwan)

^e NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

Author keywords

antidepressants; Major depressive disorder; PAWR; pharmacogenetic study; SSRI

Indexed keywords

CITALOPRAM; FLUOXETINE; PROTEINASE ACTIVATED RECEPTOR 4;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG RESPONSE; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE;

ADULT; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, THROMBIN; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 79955853178     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2010.509451     Document Type: Article

References (26)

1. Abkevich V, Camp NJ, Hensel CH, Neff CD, Russell DL, Hughes DC, et al. 2003. Predisposition locus for major depression at chromosome 12q22-12q23.2. Am J Hum Genet 73:1271-1281. (Pubitemid 38037421)
2. Ainsworth K, Smith SE, Zetterstrom TS, Pei Q, Franklin M, Sharp T. 1998. Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat. Psychopharmacology (Berlin) 140:470-477. (Pubitemid 28566846)
3. Anisman H, Irwin J, Sklar LS. 1979a. Deficits of escape performance following catecholamine depletion: implications for behavioral deficits induced by uncontrollable stress. Psychopharmacology (Berlin) 64:163-170. (Pubitemid 9236015)
4. Anisman H, Remington G, Sklar LS. 1979b. Effect of inescapable shock on subsequent escape performance: catecholaminergic and cholinergic mediation of response initiation and maintenance. Psychopharmacology (Berlin) 61:107-124. (Pubitemid 9235846)
5. Bibb JA. 2005. Decoding dopamine signaling. Cell 122:153-155. (Pubitemid 41032979)
6. Burke WJ, Hendricks SE, McArthur-Campbell D, Jacques D, Stull T. 1996. Fluoxetine and norfl uoxetine serum concentrations and clinical response in weekly versus daily dosing. Psychopharmacol Bull 32:27-32. (Pubitemid 26176198)
7. Cheng AT, Tien AY, Chang CJ, Brugha TS, Cooper JE, Lee CS, et al. 2001. Cross-cultural implementation of a Chinese version of the Schedules for Clinical Assessment in Neu-ropsychiatry (SCAN) in Taiwan. Br J Psychiatry 178: 567-572. (Pubitemid 32531753)
8. Dudbridge F. 2008. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66:87-98. (Pubitemid 351482562)
9. Dunlop BW, Nemeroff CB. 2007. The role of dopamine in the patho-physiology of depression. Arch Gen Psychiatry 64:327-337.
10. Elhwuegi AS. 2004. Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 28: 435-451. (Pubitemid 38490755)
11. Kapur S, Remington G. 1996. Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 153: 466-476. (Pubitemid 26113309)
12. Kishi T, Ikeda M, Kitajima T, Suzuki T, Yamanouchi Y, Kinoshita Y, Kawashima K, Ozaki N, Iwata N. 2008. No association between prostate apoptosis response 4 gene (PAWR) in schizophrenia and mood disorders in a Japanese population. Am J Med Genet B Neuropsychiatr Genet 147B:531-534. (Pubitemid 351830817)
13. Klimke A, Larisch R, Janz A, Vosberg H, Müller-Gärtner HW, Gaebel W. 1999. Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT. Psychiatry Res 90:91-101. (Pubitemid 29256139)
14. Liou YJ, Chen TJ, Tsai SJ, Yu YW, Cheng CY, Hong CJ. 2009. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment. Pharmacogenet Genomics 19:735-741.
15. Mattson MP, Gleichmann M. 2005. The neuronal death protein par-4 mediates dopaminergic synaptic plasticity. Mol Interv 5:278-281. (Pubitemid 41595459)
16. McGuffin P, Knight J, Breen G, Brewster S, Boyd PR, Craddock N, et al. 2005. Whole genome linkage scan of recurrent depressive disorder from the depression network study. Hum Mol Genet 14:3337-3345. (Pubitemid 41672118)
17. Papp M, Klimek V, Willner P. 1994. Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology (Berlin) 115:441-446. (Pubitemid 24248433)
18. Park SK, Nguyen MD, Fischer A, Luke MP, Affar el B, Dieffenbach PB, et al. 2005. Par-4 links dopamine signaling and depression. Cell 122:275-287. (Pubitemid 41032990)
19. Schildkraut JJ. 1965. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509-522.
20. Sells SF, Wood DP Jr, Joshi-Barve SS, Muthukumar S, Jacob RJ, Crist SA, et al. 1994. Commonality of the gene pro grams induced by effectors of apoptosis in androgen-dependent and -independent prostate cells. Cell Growth Differ 5:457-466. (Pubitemid 24251397)
21. Serretti A, Kato M, Kennedy JL. 2008. Pharmacogenetic studies in depression: a proposal for methodologic guidelines. Pharma-cogenomics J 8:90-100. (Pubitemid 351411545)
22. Sham PC, Curtis D. 1995. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97-105.
23. Sullivan PF. 2007. Spurious genetic associations. Biol Psychiatry 61:1121-1126. (Pubitemid 46669468)
24. Tsai SJ, Liou YJ, Hong CJ, Yu YW, Chen TJ. 2008. Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder. Phar-macogenomics J 8:384-390.
25. Zhao JH. 2004. 2LD, GENECOUNTING and HAP: Computer programs for linkage disequilibrium analysis. Bioinformatics 20:1325-1326. (Pubitemid 38807588)
26. Zhao JH, Lissarrague S, Essioux L, Sham PC. 2002. GENE-COUNTING: haplotype analysis with missing genotypes. Bioinformatics 18:1694-1695. (Pubitemid 36097739)